I find it appealing (compared to other OTC tickers) they haven't been diluting or messing with their SS. They have a product. They have a CEO who makes himself available; including forward looking statements towards a new direction. The CEO (through phone conversations) is honest about pros and cons about current situation and this far has held true to his word. Now I highly doubt this appeals to you and I'm not truly interested in your negative rebuttal. You can hate the stock, I'll like it.
News 
Market Data 
Discover 
